Pharvinex Chempharm Pvt. Ltd. is set to revolutionize the pharmaceutical landscape with their latest Bulk Drugs & Intermediates Project located in Bhimpura, Kota, Rajasthan. This ambitious venture, backed by a 6 Crores investment, is poised to make a significant impact in the drug manufacturing sector. With a focus on producing bulk drugs and intermediates, the project aims to cater to the growing demands of the pharmaceutical industry.
The state-of-the-art facility is designed to handle a substantial production capacity of 7466 tonnes per annum (TPA). This scale of production is set to enhance the company's market presence and meet the increasing need for high-quality pharmaceutical intermediates. By leveraging advanced technology and streamlined processes, Pharvinex Chempharm aims to deliver superior products efficiently and consistently.
The Bhimpura site will be a hub of innovation and excellence, reflecting Pharvinex Chempharm's commitment to advancing healthcare through cutting-edge manufacturing practices. As the project progresses, it promises to bolster the company's reputation as a key player in the pharmaceutical industry, driving growth and fostering new opportunities.
News by Rahul Yelligetti